ArticleResearch and practice in thrombosis and haemostasis2018

Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism.

Manuela Albisetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.